Changes in myocardial ischemic burden following percutaneous coronary intervention of chronic total occlusions

David M Safley1, Sindhu Koshy, J Aaron Grantham

  • 1Mid America Heart and Vascular Institute, St. Luke's Hospital, Kansas City, Missouri, USA. dsafley@cc-pc.com

Insights

Percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) effectively reduces myocardial ischemia, especially in patients with high baseline ischemia. A 12.5% ischemic burden threshold predicts improvement after PCI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Myocardial Perfusion Imaging

Background:

  • Optimal treatment for coronary artery chronic total occlusion (CTO) remains debated.
  • Current selection criteria for percutaneous coronary intervention (PCI) in CTO are subjective.

Purpose of the Study:

  • To assess the potential of CTO PCI to decrease myocardial ischemia.
  • To establish objective criteria for predicting post-PCI improvement.

Main Methods:

  • Retrospective analysis of 301 patients undergoing CTO PCI with pre- and post-PCI myocardial perfusion imaging (MPI).
  • Ischemic burden quantified using summed difference scores from MPI.
  • Receiver operating characteristic (ROC) curve analysis to determine predictive thresholds for ischemia reduction.

Main Results:

  • Average ischemic burden decreased from 13.1% to 6.9% post-PCI (P < 0.001).
  • 53.5% of patients achieved significant improvement (≥5% decrease in ischemic myocardium).
  • A baseline ischemic burden of 12.5% was optimal for predicting improvement; <6.25% predicted increased burden.

Conclusions:

  • CTO PCI effectively reduces ischemic burden, with greater reduction in patients with higher baseline ischemia.
  • A baseline ischemic burden threshold of 12.5% is proposed as a criterion for considering CTO PCI.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...